TokyoTokyo Mon - Fri 10:00-18:00 +81 (368) 662-975
info@mountequitygroup.com

Big business lobbies bitterly divided over drug pricing reform

Mount Equity Group Tokyo, Japan > News > Business > Big business lobbies bitterly divided over drug pricing reform

WASHINGTON — Groups representing companies like Apple, Tesla, and Boeing are clashing with Washington’s wealthiest business lobby over Democrats’ efforts to bring down drug prices.

The biggest-spending lobbying organization in the country, the U.S. Chamber of Commerce, adamantly opposes Democrats’ ideas for drug pricing reform, saying they are unwelcome government price controls. But other groups representing the largest businesses in the country, including Walmart, Tesla, Apple, Microsoft, IBM, Boeing, and The Walt Disney Company, have demanded wide-reaching reforms to help lower the cost of insuring their employees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and…

Read more…